PreveCeutical Medical Inc. is a Canada-based health sciences company. The Companyâs principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Companyâs pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Companyâs subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.
More about the company